|
|
|
Insider
Information: |
Wolff Henry Ward |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
207,058 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$108,455 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
207,058 |
|
|
Total
Value |
$108,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sangamo Biosciences Inc |
SGMO |
Exec VP & CFO |
2015-12-12 |
206,829 |
|
0 |
Premium* |
|
Nuvelo Inc |
ABIO |
Sr. VP Finance and CFO |
2006-11-30 |
229 |
2006-11-30 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGMO |
Sangamo Biosciences Inc |
Executive VP and CFO |
|
2007-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
101,000 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2011-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
164,453 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2012-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
211,219 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-12-15 |
4 |
D |
$14.74 |
$589,587 |
D/D |
(40,004) |
210,849 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
250,853 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
235,372 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2013-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
248,219 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2013-12-12 |
4 |
D |
$12.12 |
$252,969 |
D/D |
(20,872) |
227,347 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2020-07-02 |
4 |
D |
$18.00 |
$323,280 |
D/D |
(17,960) |
0 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-04-10 |
4 |
AS |
$15.72 |
$235,798 |
D/D |
(15,000) |
225,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-05-12 |
4 |
AS |
$12.85 |
$192,756 |
D/D |
(15,000) |
224,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-06-10 |
4 |
AS |
$15.62 |
$234,328 |
D/D |
(15,000) |
222,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-07-10 |
4 |
AS |
$13.19 |
$198,902 |
D/D |
(15,000) |
220,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-12-12 |
4 |
D |
$3.05 |
$42,023 |
D/D |
(13,778) |
206,829 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-04-10 |
4 |
OE |
$7.73 |
$100,490 |
D/D |
13,000 |
240,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-05-12 |
4 |
OE |
$7.73 |
$100,490 |
D/D |
13,000 |
239,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-06-10 |
4 |
OE |
$7.73 |
$100,490 |
D/D |
13,000 |
237,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2014-07-10 |
4 |
OE |
$7.28 |
$99,590 |
D/D |
13,000 |
235,347 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-01-12 |
4 |
AS |
$15.87 |
$190,450 |
D/D |
(12,000) |
208,849 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-02-10 |
4 |
AS |
$12.63 |
$151,750 |
D/D |
(12,000) |
206,849 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-03-10 |
4 |
AS |
$16.68 |
$200,201 |
D/D |
(12,000) |
204,849 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-04-10 |
4 |
AS |
$15.30 |
$183,771 |
D/D |
(12,000) |
202,849 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
|
2015-06-10 |
4 |
AS |
$12.21 |
$146,558 |
D/D |
(12,000) |
199,872 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2017-10-05 |
4 |
OE |
$5.30 |
$63,600 |
D/D |
12,000 |
12,000 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2017-10-05 |
4 |
OE |
$5.30 |
$63,600 |
I/I |
12,000 |
12,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|